Express News | Danaher Corp : BofA Global Research Raises Price Objective to $290 From $275
Danaher Is Maintained at Outperform by Evercore ISI Group
Danaher Is Poised For 'A Good Year In Bioprocessing': Analyst
Evercore ISI Adjusts Danaher Price Target to $278 From $275
Danaher Initiated at Overweight by Stephens & Co.
Danaher Analyst Ratings
Stephens Initiates Danaher(DHR.US) With Buy Rating, Announces Target Price $315
Cepheid Drives Danaher Corporation (DHR) Q2 2024 Success, Hedge Funds Rally Around the Stock
Do Its Financials Have Any Role To Play In Driving Danaher Corporation's (NYSE:DHR) Stock Up Recently?
Danaher Corporation (DHR): Why Are Billionaires Bullish on This Stock Right Now?
Telesis Bio Partners With Danaher Company Beckman Coulter
Danaher Unusual Options Activity
Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research
Danaher Schedules Third Quarter 2024 Earnings Conference Call
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
Is It Too Late To Consider Buying Danaher Corporation (NYSE:DHR)?
Don't Miss These Investor Days in September. How to Trade Them with Options
Deutsche Bank Raises Price Target on Danaher to $285 From $270
Danaher To Go Ex-Dividend On September 27th, 2024 With 0.27 USD Dividend Per Share
Danaher Keeps Quarterly Dividend at $0.27 a Share, Payable Oct. 25 to Shareholders of Record Sept. 27